Eucrates Biomedical Acquisition Corp. (EUCR)
$10.04
$0.00 (0.00%)As on 05-May-2023 09:30EDT
Market cap
$42 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
47.8
P/B Ratio
0.4
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$2 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-62.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
4,206,060
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Eucrates Biomedical Acquisition Corp (EUCR)
| 0.5 | -1.1 | -0.6 | 1.6 | -- | -- | -- |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
Company
|
2022
|
2021
|
|---|---|---|
|
Eucrates Biomedical Acquisition Corp (EUCR)
| 2.4 | -2.9 |
|
BSE Sensex
| 4.4 | 22.0 |
|
BSE Sensex
| 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Eucrates Biomedical Acquisition Corp (EUCR)
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It... focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York. Read more
-
CEO & Director
Mr. Parag Phoolchand Saxena MBA, MS
-
CEO & Director
Mr. Parag Phoolchand Saxena MBA, MS
-
Headquarters
New York, NY
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Eucrates Biomedical Acquisition Corp (EUCR)
What is the current share price of Eucrates Biomedical Acquisition Corp (EUCR) Today?
The share price of Eucrates Biomedical Acquisition Corp (EUCR) is $10.04 (NASDAQ) as of 05-May-2023 09:30 EDT. Eucrates Biomedical Acquisition Corp (EUCR) has given a return of 1.62% in the last 1 years.
What is the current PB & PE ratio of Eucrates Biomedical Acquisition Corp (EUCR)?
The P/E ratio of Eucrates Biomedical Acquisition Corp (EUCR) is 47.81 times as on 05-May-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
5.41 |
3.51 |
2021 |
3,407.03 |
0.29 |
2020 |
-- |
-- |
2022 |
5.41 |
3.51 |
2021 |
3,407.03 |
0.29 |
What is the 52 Week High and Low of Eucrates Biomedical Acquisition Corp (EUCR)?
The 52-week high and low of Eucrates Biomedical Acquisition Corp (EUCR) are Rs -- and Rs -- as of 01-Sep-2026.
What is the market cap of Eucrates Biomedical Acquisition Corp (EUCR)?
Eucrates Biomedical Acquisition Corp (EUCR) has a market capitalisation of $ 42 Mln as on 05-May-2023. As per SEBI classification, it is a company.
Should I invest in Eucrates Biomedical Acquisition Corp (EUCR)?
Before investing in Eucrates Biomedical Acquisition Corp (EUCR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.